-
Almilaji A, Szteyn K, Fein E, Pakladok T, Munoz C, Elvira B, Towhid ST, Alesutan I, Shumilina E, Bock CT, Kandolf R, Lang F, 2013: Down-regulation of Na/K+ atpase activity by human parvovirus B19 capsid protein VP1[J]. Cell Physiol Biochem, 31, 638-648. doi: 10.1159/000350083
-
Bruss V, 2007: Hepatitis B virus morphogenesis[J]. World J Gastroenterol, 13, 65-73. doi: 10.3748/wjg.v13.i1.65
-
Burkard C, Verheije MH, Haagmans BL, van Kuppeveld FJ, Rottier PJ, Bosch BJ, de Haan CA, 2015: ATP1A1-mediated Src signaling inhibits coronavirus entry into host cells[J]. J Virol, 89, 4434-4448. doi: 10.1128/JVI.03274-14
-
Chan MC, Kuok DI, Leung CY, Hui KP, Valkenburg SA, Lau EH, Nicholls JM, Fang X, Guan Y, Lee JW, Chan RW, Webster RG, Matthay MA, Peiris JS, 2016: Human mesenchymal stromal cells reduce influenza A H5N1-associated acute lung injury in vitro and in vivo[J]. Proc Natl Acad Sci USA, 113, 3621-3626. doi: 10.1073/pnas.1601911113
-
Chiampanichayakul S, Khunkaewla P, Pata S, Kasinrerk W, 2006: Na, K ATPase beta3 subunit (CD298): association with alpha subunit and expression on peripheral blood cells[J]. Tissue Antigens, 68, 509-517. doi: 10.1111/j.1399-0039.2006.00726.x
-
Chiu CC, Shi YF, Yang JJ, Hsiao YC, Tzang BS, Hsu TC, 2014: Effects of human parvovirus B19 and Bocavirus VP1 unique region on tight junction of human airway epithelial A549 cells[J]. PLoS ONE, 9, e107970-. doi: 10.1371/journal.pone.0107970
-
Chruewkamlow N, Pata S, Mahasongkram K, Laopajon W, Kasinrerk W, Chiampanichayakul S, 2015: Beta3 subunit of Na, K ATPase regulates T cell activation with no involvement of Na, K ATPase activity[J]. Immunobiology, 220, 634-640. doi: 10.1016/j.imbio.2014.11.017
-
Clausen MV, Hilbers F, Poulsen H, 2017: The structure and function of the Na, K-ATPase isoforms in health and disease[J]. Front Physiol, 8, 371-. doi: 10.3389/fphys.2017.00371
-
Cui X, Sun ZR, Ren GW, Wang GL, Qi Y, Ma YP, Ruan Q, 2011: Interaction between human cytomegalovirus UL136 protein and ATP1B1 protein[J]. Braz J Med Biol Res, 44, 1251-1255. doi: 10.1590/S0100-879X2011007500144
-
Dodson AW, Taylor TJ, Knipe DM, Coen DM, 2007: Inhibitors of the sodium potassium ATPase that impair herpes simplex virus replication identified via a chemical screening approach[J]. Virology, 366, 340-348. doi: 10.1016/j.virol.2007.05.001
-
Gao G, Luo H, 2006: The ubiquitin-proteasome pathway in viral infections[J]. Can J Physiol Pharmacol, 84, 5-14. doi: 10.1139/y05-144
-
Heermann KH, Goldmann U, Schwartz W, Seyffarth T, Baumgarten H, Gerlich WH, 1984: Large surface proteins of hepatitis B virus containing the pre-s sequence[J]. J Virol, 52, 396-402. doi: 10.1128/JVI.52.2.396-402.1984
-
Huang L, Kometiani P, Xie Z, 1997a: Differential regulation of Na/K-ATPase alpha-subunit isoform gene expressions in cardiac myocytes by ouabain and other hypertrophic stimuli[J]. J Mol Cell Cardiol, 29, 3157-3167. doi: 10.1006/jmcc.1997.0546
-
Huang L, Li H, Xie Z, 1997b: Ouabain-induced hypertrophy in cultured cardiac myocytes is accompanied by changes in expression of several late response genes[J]. J Mol Cell Cardiol, 29, 429-437. doi: 10.1016/S0735-1097(97)87457-8
-
Iwamoto M, Saso W, Sugiyama R, Ishii K, Ohki M, Nagamori S, Suzuki R, Aizaki H, Ryo A, Yun JH, Park SY, Ohtani N, Muramatsu M, Iwami S, Tanaka Y, Sureau C, Wakita T, Watashi K, 2019: Epidermal growth factor receptor is a host-entry cofactor triggering hepatitis B virus internalization[J]. Proc Natl Acad Sci USA, 116, 8487-8492. doi: 10.1073/pnas.1811064116
-
Kaplan JH, 2002: Biochemistry of Na, K-ATPase[J]. Annu Rev Biochem, 71, 511-535. doi: 10.1146/annurev.biochem.71.102201.141218
-
Kapoor A, Cai H, Forman M, He R, Shamay M, Arav-Boger R, 2012: Human cytomegalovirus inhibition by cardiac glycosides: evidence for involvement of the HERG gene[J]. Antimicrob Agents Chemother, 56, 4891-4899. doi: 10.1128/AAC.00898-12
-
Li Z, Huan C, Wang H, Liu Y, Liu X, Su X, Yu J, Zhao Z, Yu XF, Zheng B, Zhang W, 2020: TRIM21-mediated proteasomal degradation of SAMHD1 regulates its antiviral activity[J]. EMBO Rep, 21, e47528-.
-
Liu Y, Wang H, Zhang J, Yang J, Bai L, Zheng B, Zheng T, Wang Y, Li J, Zhang W, 2020: SERINC5 inhibits the secretion of complete and genome-free hepatitis B virions through interfering with the glycosylation of the HBV envelope[J]. Front Microbiol, 11, 697-. doi: 10.3389/fmicb.2020.00697
-
Lu Y, Hou H, Wang F, Qiao L, Wang X, Yu J, Liu W, Sun Z, 2016: ATP1B3: a virus-induced host factor against EV71 replication by up-regulating the production of type-I interferons[J]. Virology, 496, 28-34. doi: 10.1016/j.virol.2016.05.013
-
Luo H, 2016: Interplay between the virus and the ubiquitin-proteasome system: molecular mechanism of viral pathogenesis[J]. Curr Opin Virol, 17, 1-10. doi: 10.1016/j.coviro.2015.09.005
-
Luo H, Wong J, Wong B, 2010: Protein degradation systems in viral myocarditis leading to dilated cardiomyopathy[J]. Cardiovasc Res, 85, 347-356. doi: 10.1093/cvr/cvp225
-
Mi S, Li Y, Yan J, Gao GF, 2010: Na(+)/K(+)-ATPase beta1 subunit interacts with M2 proteins of influenza A and B viruses and affects the virus replication[J]. Sci China Life Sci, 53, 1098-1105.
-
Mohammadi K, Kometiani P, Xie Z, Askari A, 2001: Role of protein kinase C in the signal pathways that link Na+/K+-ATPase to ERK1/2[J]. J Biol Chem, 276, 42050-42056. doi: 10.1074/jbc.M107892200
-
Nishitsuji H, Sugiyama R, Abe M, Takaku H, 2016: ATP1B3 protein modulates the restriction of HIV-1 production and nuclear factor kappa light chain enhancer of activated B cells (NF-kappaB) activation by BST-2[J]. J Biol Chem, 291, 4754-4762. doi: 10.1074/jbc.M115.679357
-
Peteranderl C, Morales-Nebreda L, Selvakumar B, Lecuona E, Vadasz I, Morty RE, Schmoldt C, Bespalowa J, Wolff T, Pleschka S, Mayer K, Gattenloehner S, Fink L, Lohmeyer J, Seeger W, Sznajder JI, Mutlu GM, Budinger GR, Herold S, 2016: Macrophage-epithelial paracrine crosstalk inhibits lung edema clearance during influenza infection[J]. J Clin Invest, 126, 1566-1580. doi: 10.1172/JCI83931
-
Prassas I, Diamandis EP, 2008: Novel therapeutic applications of cardiac glycosides[J]. Nat Rev Drug Discov, 7, 926-935. doi: 10.1038/nrd2682
-
Sagnelli E, Macera M, Russo A, Coppola N, Sagnelli C, 2020: Epidemiological and etiological variations in hepatocellular carcinoma[J]. Infection, 48, 7-17. doi: 10.1007/s15010-019-01345-y
-
Schoner W, Scheiner-Bobis G, 2007: Endogenous and exogenous cardiac glycosides and their mechanisms of action[J]. Am J Cardiovasc Drugs, 7, 173-189. doi: 10.2165/00129784-200707030-00004
-
Sommer AF, Riviere L, Qu B, Schott K, Riess M, Ni Y, Shepard C, Schnellbacher E, Finkernagel M, Himmelsbach K, Welzel K, Kettern N, Donnerhak C, Munk C, Flory E, Liese J, Kim B, Urban S, Konig R, 2016: Restrictive influence of SAMHD1 on hepatitis B virus life cycle[J]. Sci Rep, 6, 26616-. doi: 10.1038/srep26616
-
Su CT, Hsu JT, Hsieh HP, Lin PH, Chen TC, Kao CL, Lee CN, Chang SY, 2008: Anti-HSV activity of digitoxin and its possible mechanisms[J]. Antiviral Res, 79, 62-70. doi: 10.1016/j.antiviral.2008.01.156
-
Ulug ET, Garry RF, Bose HR Jr, 1996: Inhibition of Na+ K+ATPase activity in membranes of Sindbis virus-infected chick cells[J]. Virology, 216, 299-308. doi: 10.1006/viro.1996.0065
-
Xie Z, 2003: Molecular mechanisms of Na/K-ATPase-mediated signal transduction[J]. Ann N Y Acad Sci, 986, 497-503. doi: 10.1111/j.1749-6632.2003.tb07234.x
-
Zheng B, Zhang J, Zheng T, Wang H, Li Z, Huan C, Ning S, Wang Y, Zhang W, 2020: ATP1B3 cooperates with BST-2 to promote hepatitis B virus restriction[J]. J Med Virol, 92, 201-209. doi: 10.1002/jmv.25599